Investigation of the drug binding properties and cytotoxicity of DNA-capped nanoparticles designed as delivery vehicles for the anticancer agents doxorubicin and actinomycin D

Bioconjugate Chemistry

Volumn 23, Issue 10, 2012, Pages 2061-2070

  Alexander, Colleen M ^a   Dabrowiak, James C ^a   Maye, Mathew M ^a  

^a SYRACUSE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; CONTROLLED DRUG DELIVERY; DISSOCIATION; DNA SEQUENCES; ELECTROPHORESIS; GOLD NANOPARTICLES; OLIGONUCLEOTIDES; RATE CONSTANTS; SURFACE PLASMON RESONANCE; SYNTHESIS (CHEMICAL); TARGETED DRUG DELIVERY; VEHICLES;

ACTINOMYCIN D; ANTI-CANCER AGENTS; BINDING PROPERTIES; DELIVERY VEHICLE; DOXORUBICIN; DRUG BINDING; DRUG LOADING; FUNCTIONALIZED GOLD NANOPARTICLES; HIGH AFFINITY; SYNTHESISED;

DNA;

DACTINOMYCIN; DOXORUBICIN; DRUG VEHICLE; GOLD NANOPARTICLE;

AGAR GEL ELECTROPHORESIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DRUG BINDING; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; IC 50; INTERCALATION COMPLEX;

EID: 84867520847     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc3002634     Document Type: Article

References (55)

1. Hunter, R. J. and Preedy, V. R., Ed. (2011) Nanomedicine in Health and Disease, Science Publishers, St. Helier, Jersey, British Channel Islands.
2. Lamprecht, A., Ed. (2009) Nanotherapeutics: Drug Delivery Concepts in Nanoscience, Pan Stanford Publishing, Singapore.
3. Dabrowiak, J. C. (2009) Metals in Medicine, pp 283-310, Chapter 9, Wiley, United Kingdom.
4. Llevot, A. and Astruc, D. (2011) Applications of vectorized gold nanoparticles to the diagnosis and therapy of cancer Chem. Soc. Rev. 41, 242-257
5. Dreaden, E. C., Mackey, M. A., Huang, X., Kang, B., and El-Sayed, M. A. (2011) Beating cancer in multiple ways using nanogold Chem. Soc. Rev. 40, 3391-3404
6. Kudgus, R. A., Bhattacharya, R., and Mukherjee, P. (2011) Cancer nanotechnology: emerging role of gold nanoconjugates Anticancer Agents Med. Chem. 10, 965-973
7. Giljohann, D. A., Seferos, D. S., Daniel, W. L., Massich, M. D., Patel, P. C., and Mirkin, C. A. (2010) Gold nanoparticles for biology and medicine Angew Chem., Int. Ed. 49, 3280-3294
8. Rana, S., Bajaj, A., Mout, R., and Rotello, V. M. (2012) Monolayer coated gold nanoparticles for delivery applications Adv. Drug Delivery Rev. 64, 200-216
9. Murphy, C. J., Gole, A. M., Stone, J. W., Sisco, P. N., Alkilany, A. M., Goldsmith, E. C., and Baxter, S. C. (2008) Gold nanoparticles in biology: beyond toxicity to cellular imaging Acc. Chem. Res. 41, 1721-1730
10. Paciotti, G. F., Myer, L., Weinreich, D., Goia, D., Pavel, N., McLaughlin, R. E., and Tamarkin, L. (2004) Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery Drug Delivery 11, 169-183 (Pubitemid 38720414)
11. Libutti, S. K., Paciotti, G. F., Byrnes, A. A., Alexander, H. R., Jr., Gannon, W. E., Walker, M., Seidel, G. D., Yuldasheva, N., and Tamarkin, L. (2010) Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold rhTNF nanomedicine Clin. Cancer Res. 16, 6139-6149
12. Dhar, S., Daniel, W. L., Giljohann, D. A., Mirkin, C. A., and Lippard, S. J. (2009) Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads J. Am. Chem. Soc. 131, 14652-14653
13. Rosi, N. L., Giljohann, D. A., Thaxton, C. S., Lytton-Jean, A. K. R., Han, M. S., and Mirkin, C. A. (2006) Oligonucleotide-modified gold nanoparticles for intracellular gene regulation Science 312, 1027-1030
14. Giljohann, D. A., Seferos, D. S., Patel, P. C., Millstone, J. E., Rosi, N. L., and Mirkin, C. A. (2007) Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles Nano Lett. 12, 3818-3821
15. Patel, P. C., Giljohann, D. A., Daniel, W. L., Zheng, D., Prigodich, A. E., and Mirkin, C. A. (2010) Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles Bioconjugate Chem. 21, 2250-2256
16. Nitin, N., Javier, D. J., and Richards-Kortum, R. (2007) Oligonucleotide-coated metallic nanoparticles as a flexible platform for molecular imaging agents Bioconjugate Chem. 18, 2090-2096 (Pubitemid 350220013)
17. Yu, M. K., Park, J., Jeong, Y. Y., Moon, W. K., and Jon, S. (2010) Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery Nanotechnology 21, 415102/1-415102/9
18. Brown, S. D., Nativo, P., Smith, J., Stirling, D., Edwards, P. R., Venugopal, B., Flint, D. J., Plumb, J. A., Graham, D., and Wheate, N. J. (2010) Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin J. Am. Chem. Soc. 132, 4678-4684
19. Zhang, X., Chibli, H., Mielke, R., and Nadeau, J. (2010) Ultrasmall gold-doxorubicin conjugates rapidly kill apoptosis-resistant cancer cells Bioconjugate Chem. 22, 235-243
20. Alexander, C. M., Maye, M. M., and Dabrowiak, J. C. (2011) DNA-capped nanoparticles designed for doxorubicin drug delivery Chem. Commun. 47, 3418-3420
21. Chaires, J. B. and Herrera, J. E. (1990) Preferential binding of daunomycin to 5′A/TCG and 5′A/TGC s equences revealed by footprinting titration experiments Biochemistry 29, 6145-6153 (Pubitemid 20222228)
22. Trist, H. and Phillips, D. R. (1989) In vitro transcription analysis of the role of flanking sequence on the DNA sequence specificity of Adriamycin Nucleic Acids Res. 17, 3673-3688 (Pubitemid 19153357)
23. Sha, F. and Chen, M. F. (2000) Actinomycin D binds strongly to d(CGACGACG) and d(CGTCGTCG) Biophys. J. 79, 2095-2104
24. Chen, M. F., Sha, F., Chin, K., and Chou, S. (2003) Binding of Actinomycin D to single-stranded DNA of sequence motifs d(TGTCTnG) and d(TGTnGTCT) Biophys. J. 84, 432-439 (Pubitemid 36026411)
25. Maye, M. M., Nykypanchuk, D., Van der Lelie, D., and Gang, O. (2006) A simple method for kinetic control of DNA-induced nanoparticle assembly J. Am. Chem. Soc. 128, 14020-14021 (Pubitemid 44657482)
26. Freeman, R. G., Hommer, M. B., Grabar, K. C., Jackson, M. A., and Natan, M. J. (1996) Ag-Clad Au nanoparticles: novel aggregation, optical, and surface-enhanced raman scattering properties J. Phys. Chem. 100, 718-724 (Pubitemid 126803858)
27. Hurst, S. J., Lytton-Jean, A. K. R., and Mirkin, C. A. (2006) Maximizing DNA loading on a range of gold nanoparticle sizes Anal. Chem. 78, 8313-8318 (Pubitemid 44932099)
28. Lytton-Jean, A. K. R. and Mirkin, C. A. (2005) A thermodynamic investigation into the binding properties of DNA functionalized gold nanoparticle probes and molecular fluorophore probes J. Am. Chem. Soc. 127, 12754-12755 (Pubitemid 41339136)
29. Demers, L. M., Mirkin, C. A., Mucic, R. C., Reynolds, R. A., Letsinger, R. L., Elghanian, R., and Viswanadham, G. (2000) A fluorescence-based method for determining the surface coverage and hybridization efficiency of thiol-capped oligonucleotides bound to gold thin films and nanoparticles Anal. Chem. 72, 5535-5541
30. Gabbay, E. J., Grier, D., Fingerle, R. E., Riemer, R., Levy, R., Pearce, S. W., and Wilson, W. D. (1976) Interaction specificity of the anthracyclines with deoxyribonucleic acid Biochemistry 15, 2062-2070
31. Vives, M., Tauler, R., Eritja, R., and Gargallo, R. (2007) Spectroscopic study of the interaction of actinomycin D with oligonucleotides carrying the central base sequences -XGCY- and -XGGCCY- using multivariate methods Anal. Bioanal. Chem. 387, 311-320 (Pubitemid 44956283)
32. Frederick, C. A., Williams, L. D., Ughetto, G., van der Marel, G. A., van Boom, J. H., Rich, A., and Wang, A. H. (1990) Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin Biochemistry 29, 2538-2549 (Pubitemid 20100850)
33. Wheate, N. J., Brodie, C. R., Collins, J. G., Kemp, S., and Aldrich-Wright, J. R. (2007) DNA intercalators in cancer chemotherapy: organic and inorganic drugs and their spectroscopic tools of analysis Minirev. Med. Chem. 7, 627-648 (Pubitemid 47099183)
34. Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. D., and Liu, L. F. (1984) Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II Science 226, 466-468 (Pubitemid 14012819)
35. Bailey, S. A., Graves, D. E., Rill, R., and Marsch, G. (1993) Influence of DNA base sequence on the binding energetics of actinomycin D Biochemistry 32, 5881-5887 (Pubitemid 23175692)
36. Chen, F. (1988) Kinetic and equilibrium binding studies of actinomycin D with some d(TGCA)-containing dodecamers Biochemistry 27, 1843-1845
37. Müller, W. and Crothers, D. M. (1968) Studies of the binding of actinomycin and related compounds to DNA J. Mol. Biol. 35, 251-290
38. Sartiano, G. P., Lynch, W. E., and Bullington, W. D. (1979) Mechanism of action of the anthracycline anti-tumor antibiotics, doxorubicin, daunomycin, and rubidazone: preferential inhibition of DNA polymerase α J. Antibiot. 32, 1038-1045 (Pubitemid 10071244)
39. Avendaño, C. and Menéndez, J. C. (2008) Medicinal Chemistry of Anticancer Drugs, Elsevier Science, Oxford.
40. Nowicka, A. M., Kowalczyk, A., Donten, M., Krysinski, P., and Stojek, Z. (2009) Influence of a magnetic nanoparticle as a drug carrier on the activity of anticancer drugs: interactions of double stranded DNA and doxorubicin modified with a carrier Anal. Chem. 81, 7474-7483
41. Zhang, R., Wu, X., Yalowich, J. C., and Hasinoff, B. B. (2011) Design, synthesis, and biological evaluation of a novel series of bisintercalating DNA-binding piperazine-linked bisanthrapyrazole compounds as anticancer agents Bioorg. Med. Chem. 19, 7023-7032
42. Reinert, K. E., Stutter, E., and Schweiss, H. (1979) Aspects of specific protein-DNA interaction; multi-mode binding of the oligopeptide antibiotic netropsin to (A-T)-rich segments Nucleic Acids Res. 7, 1375-1392 (Pubitemid 10045286)
43. Reinert, K. E. (1981) Apsects of specific DNA-protein interaction; local bending of DNA molecules by in-register binding of the oligopeptide antibiotic distamycin Biophys. Chem. 13, 1-14 (Pubitemid 11091227)
44. Breslin, D. T., Coury, J. E., Anderson, J. R., McFail-Isom, L., Yongzhi, K., Dean Williams, L., Bottomley, L. A., and Schuster, G. B. (1997) Anthraquinone photonuclease structure determines its mode of binding to DNA and the cleavage chemistry observed J. Am. Chem. Soc. 119, 5043-5044 (Pubitemid 27272495)
45. Mirau, P. A. and Shafer, R. H. (1982) Role of actinomycin pentapeptides in actinomycin-deoxyribonucleic acid binding and kinetics Biochemistry 21, 2626-2631 (Pubitemid 12000390)
46. 1H NMR spectroscopy J. Mol. Biol. 262, 53-68 (Pubitemid 26315992)
47. Parak, W. J., Pellegrino, T., Micheel, C. M., Gerion, D., Williams, S. C., and Alivisatos, A. P. (2003) Conformation of oligonucleotides attached to gold nanocrystals probed by gel electrophoresis Nano Lett. 3, 33-36 (Pubitemid 37161847)
48. Patra, H. K., GuhaSarkar, D., and Dasgupta, A. K. (2009) Multimodal electrophoresis of gold nanoparticles: A real time approach Anal. Chim. Acta 649, 128-134
49. Pons, T., Uyeda, H. T., Medintz, I. L., and Mattoussi, H. (2006) Hydrodynamic dimensions, electrophoretic mobility, and stability of hydrophilic quantum dots J. Phys. Chem. B 110, 20308-20316 (Pubitemid 44797455)
50. Chaires, J. B., Dattagupta, N., and Crothers, D. M. (1985) Kinetics of the daunomycin-DNA interaction Biochemistry 24, 260-267 (Pubitemid 15105605)
51. Stutter, E. and Forster, W. (1979) On the kinetics of daunomycin-DNA interaction Stud. Biophys. 75, 199-208 (Pubitemid 10245775)
52. Gandecha, B. M. and Brown, J. R. (1985) Dissociation kinetics of DNA-anthracycline and DNA-anthraquinone complexes determined by stopped-flow spectrophotometry Biochem. Pharmacol. 34, 733-736 (Pubitemid 15107164)
53. Brown, S. C. and Shafer, R. H. (1987) Kinetic studies of Actinomycin D binding to mono-, oligo-, and polynucleotides Biochemistry 26, 277-282 (Pubitemid 17014432)
54. Rizzo, V., Sacchi, N., and Menozzi, M. (1989) Kinetic studies of anthracycline-DNA interaction by fluorescence stopped flow confirm a complex association mechanism Biochemistry 28, 274-282 (Pubitemid 19046742)
55. Arcamone, F. (1981) Doxorubicin, anticancer antibiotics, Vol. 17, Medicinal Chemistry Series, Academic Press, New York.